|
Net sales
|
|
$177.4m
|
$167.4m
|
$276.7m
|
$247.5m
|
$191.2m
|
$201.1m
|
$222.3m
|
$190.5m
|
|
Cost of sales
|
|
$93.9m
|
$96.4m
|
$149.9m
|
$133.3m
|
$103.1m
|
$112.7m
|
$123.1m
|
$105.3m
|
|
Gross profit
|
|
$83.5m
|
$71.0m
|
$126.8m
|
$114.2m
|
$88.1m
|
$88.4m
|
$99.3m
|
$85.2m
|
|
Research and development
|
|
$4.9m
|
$5.0m
|
$5.4m
|
$5.5m
|
$6.4m
|
$6.9m
|
$7.7m
|
$6.1m
|
|
Total operating expenses
|
|
$97.5m
|
$183.8m
|
$103.3m
|
$170.8m
|
$100.8m
|
$100.9m
|
$99.4m
|
$94.2m
|
|
(Loss)/income from operations before income taxes
|
|
($8.8m)
|
($107.9m)
|
$24.3m
|
($55.5m)
|
($12.3m)
|
($12.3m)
|
$46k
|
($9.2m)
|
|
Selling, marketing, and distribution
|
|
$32.0m
|
$38.6m
|
$56.8m
|
$56.2m
|
$51.8m
|
$55.0m
|
$55.6m
|
$51.7m
|
|
General and administrative
|
|
$50.3m
|
$41.3m
|
$41.2m
|
$41.2m
|
$42.6m
|
$39.0m
|
$36.1m
|
$32.9m
|
|
Impairment of assets held for sale
|
|
—
|
—
|
—
|
—
|
—
|
$0
|
$0
|
$3.4m
|
|
Operating loss
|
|
($14.1m)
|
($112.8m)
|
$23.5m
|
($56.5m)
|
($12.7m)
|
($12.5m)
|
($154k)
|
($9.0m)
|
|
Other income, net
|
|
$54k
|
($21k)
|
$497k
|
$1.3m
|
$1.2m
|
$140k
|
$140k
|
$113k
|
|
Net loss
|
|
($9.5m)
|
($96.2m)
|
$18.4m
|
($64.9m)
|
($12.0m)
|
($12.2m)
|
($77k)
|
($9.2m)
|
|
Basic (in dollars per share)
|
|
($0.68)
|
($6.88)
|
$1.31
|
($4.66)
|
($0.90)
|
($0.94)
|
($0.01)
|
($0.73)
|
|
Diluted (in dollars per share)
|
|
($0.68)
|
($6.88)
|
$1.29
|
($4.66)
|
($0.90)
|
($0.94)
|
($0.01)
|
($0.73)
|
|
Interest (expense)/income, net
|
|
$5.2m
|
$5.0m
|
$300k
|
($324k)
|
($761k)
|
$39k
|
$60k
|
($276k)
|
|
Income tax expense/(benefit)
|
|
$734k
|
($11.7m)
|
$5.9m
|
$9.3m
|
($249k)
|
($70k)
|
$123k
|
$45k
|
|
Total other (expense)/income, net
|
|
$5.3m
|
$4.9m
|
$797k
|
$987k
|
$427k
|
$179k
|
$200k
|
($163k)
|